Biolargo Inc (OP:BLGO)

0.0725 UNCHANGED

Delayed Quote Updated: 3:43 PM EDT, Oct 19, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	0.0725
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0725
Today's Range	0.0725 - 0.0725
52wk Range	0.0675 - 0.1960
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioLargo Subsidiary Clyra Medical to Exhibit at SAWC Fall 2026 in Las Vegas

October 13, 2026

Clyra and national launch partner Advanced Solution will feature ViaCLYR™, the copper-iodine wound irrigation solution, at the Symposium on Advanced Wound Care, October 15-18

From BioLargo, Inc

Via ACCESS Newswire

Gabelli To Host 4th Annual PFAS Symposium

September 16, 2026

From Gabelli Funds

Via GlobeNewswire

Performance

52-Week Range 63.0% below 52-week high

0.0725

0.0752W Low 0.2052W High

1 Week 13.6% below 1-week high

0.071W Low 0.081W High

Biolargo Inc (BLGO) traded between $0.07 and $0.20 over the past 52 weeks and last traded at $0.07, 63.0% below its 52-week high. Over the past week it ranged between $0.07 and $0.08.

Past 12 Months

-7.4%

-21.2%

-33.8%

-51.7%

-61.4%

1W -$0.01

1M -$0.02

3M -$0.04

6M -$0.08

YTD -$0.12

1Y -$0.12

BLGO was -61.4% over the past year, -51.7% over six months, -61.4% year to date, -7.4% in the last week.

12 Months vs Market

BLGO

-61.4%

DIA

+11.1%

SPY

+14.2%

QQQ

+17.5%

IWM

+9.3%

Over the past 12 months BLGO returned -61.4% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity

322.8K

425.9K

408.5K

435.8K

YTD

370.2K

380.4K

BLGO's 3-month average daily volume is 408.5K.

More News

BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and More

September 10, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern Time

September 09, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution

September 03, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026

September 01, 2026

From BioLargo, Inc.

Via ACCESS Newswire

BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York

August 25, 2026

From BioLargo, Inc

Via ACCESS Newswire

Gabelli To Host 4th Annual PFAS Symposium

August 24, 2026

From Gabelli Funds

Via GlobeNewswire

BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%

August 17, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo's Lake Stockholm AEC Installation passes six months of PFAS remediation Topping Two Million Gallons

August 03, 2026

From BioLargo, Inc.

Via ACCESS Newswire

BioLargo Joins New Jersey Institute of Technology-Led PFAS Consortium; President Tonya Chandler Appointed to Board of Directors

July 30, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Equipment Solutions & Technologies' "PFAS Lady" to Teach PFAS 101 at 41st Annual Tri-State Seminar

July 29, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo PFAS Treatment Technology Featured in The Disruptive Quarterly

July 27, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Relaunching CupriDyne(R)-Based Consumer Products - Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales

July 13, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals

July 01, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets

May 05, 2026

Via ACCESS Newswire

BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology

May 04, 2026

Via ACCESS Newswire

BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026

May 04, 2026

Via ACCESS Newswire

BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery

April 20, 2026

Via ACCESS Newswire

BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum

April 01, 2026

Via ACCESS Newswire

BioLargo Reports Annual 2025 Operating and Financial Results

March 05, 2026

Via ACCESS Newswire

BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time

March 04, 2026

Via ACCESS Newswire

BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium

February 18, 2026

Via ACCESS Newswire

BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution

February 09, 2026

Via ACCESS Newswire

BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST

January 16, 2026

Via ACCESS Newswire

Frequently Asked Questions

Is Biolargo Inc publicly traded?

Yes, Biolargo Inc is publicly traded.

What exchange does Biolargo Inc trade on?

Biolargo Inc trades on the OTC Traded

What is the ticker symbol for Biolargo Inc?

The ticker symbol for Biolargo Inc is BLGO on the OTC Traded

What is the current price of Biolargo Inc?

The current price of Biolargo Inc is 0.0725

When was Biolargo Inc last traded?

The last trade of Biolargo Inc was at 10/19/26 03:43 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.